WENA - Anew Medical Forward P/E Multiple

Official company branding of Anew Medical (WENA)

Anew Medical, Inc. (WENA) focuses on Alpha-klotho protein gene therapy to combat neurodegeneration. The company delegates manufacturing processes and testing to external contractors to maintain flexibility. However, the concentration on early-stage treatments for ALS and Alzheimer's creates high binary risks. The business's forward P/E illustrates the ratio of the share price to expected earnings, where this metric equals 0.00.

Anew Medical Inc. - WENA Projected Price to Earnings (period 06/25/2024 - 09/17/2024)

Metric breakdowns and analytics for Anew Medical (WENA)

- stock value and consensus price forecast:
Analysis of all company metrics:Anew Medical, Inc.
Signature product of anewmeds.com

To objectively measure the operational success of Anew Medical, Inc. (WENA), investors must weigh market expectations against the commercialization potential of its protein delivery patents. By analyzing the company's forward P/E ratio, recorded at 0.00, one can determine the number of years of future earnings priced into the stock, which, in the absence of debt, allows for an assessment of the long-term value of its biotechnological developments.

Who Anew Medical, Inc. competes with

Forward P/E Multiple BIIB|NBIX - Projected Price to Earnings Ratio|Forward P/E Multiple RGC (Regencell Bioscience Ltd)|Market Cap to Projected Earnings axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Forward P/E Multiple|Projected Price to Earnings Ratio Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Future Price to Earnings|Supernus Corp - Future Price to Earnings Multiple|Projected Price to Earnings CPRX|Denali Therapeutics Inc. (DNLI) - Market Cap to Projected Earnings|Projected Price to Earnings HRMY (Harmony Corp)|BHVN - Projected Price to Earnings Ratio|Future Price to Earnings Amylyx Pharmaceuticals, Inc. AMLX|Future Price to Earnings Multiple TRVI|PRAX - Future Price to Earnings|Market Cap to Projected Earnings Anavex Life Sciences AVXL|CBLL: Forward P/E Multiple|Projected Price to Earnings Prothena Corporation PLC|ALEC (alector.com) - Forward P/E Multiple|Projected Price to Earnings Annexon, Inc. (ANNX)|Future Price to Earnings Omeros Corporation (OMER)|Neurogene Inc. - Price to Future Earnings Ratio|acimmune.com - Projected Price to Earnings|Forward P/E Multiple Voyager Therapeutics Inc VYGR|NMRA - Future Price to Earnings|Forward Price to Earnings Multiple Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Future Price to Earnings|Price to Future Earnings Ratio ACOG|Future Price to Earnings Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Price to Expected Earnings Ratio|Projected Price to Earnings SAVA (Cassava)|Market Cap to Projected Earnings Assertio Therapeutics|Coya Therapeutics, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - Forward P/E Multiple|Acumen Pharmaceuticals, Inc. (ABOS) - Projected Price to Earnings|CRVO (CervoMed, Inc.) - Projected Price to Earnings|Projected Price to Earnings Alterity Therapeutics Ltd|Future Price to Earnings Clene Inc.|PepGen Inc. - Price to Expected Earnings Ratio|Projected Price to Earnings JUNS (Jupiter Neurosciences Inc)|Future Price to Earnings RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Projected Price to Earnings|Market Cap to Projected Earnings Grace Tx (GRCE)|fireflyneuro.com - Forward P/E Multiple|Klotho Neurosciences (KLTO) - Projected Price to Earnings|NeuroSense Therapeutics, Ltd. (NRSN) - Future Price to Earnings|Price to Expected Earnings Ratio RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - Forward P/E Multiple|NRXS: Future Price to Earnings Multiple|Forward P/E Multiple HSDT|Forward P/E Multiple Passage Bio Inc. (PASG)|Future Price to Earnings bionomics.com.au NEUP|Forward P/E Multiple Minerva Neurosciences Inc NERV|ATHA: Projected Price to Earnings|ADXN (Addex Therapeutics, Ltd.) - Price to Future Earnings Ratio|Alzamend Neuro Inc. (ALZN) - Future Price to Earnings|Cyclerion - Future Price to Earnings Multiple|Future Price to Earnings protagenic.com|Pasithea Therapeutics - Price to Expected Earnings Ratio|Projected Price to Earnings CRGT (Cortigent, Inc.)|Avenue Therapeutics - Price to Future Earnings Ratio|Future Price to Earnings Brainstorm Cell BCLI|Forward P/E Multiple caratherapeutics.com CARA|Chromocell Therapeutics Corp. - Forward P/E Multiple|eliemtx.com - Market Cap to Future Earnings Ratio|Intra-Cellular Therapies (ITCI) - Future Price to Earnings|LBPH (Longboard) - Future Price to Earnings|MRNS (marinuspharma.com) - Forward P/E Multiple|Projected Price to Earnings Ratio NKGen Biotech NKGN|Future Price to Earnings NeuroBo Pharma (NRBO)|Market Cap to Future Earnings Ratio SAGE|Synaptogenix, Inc. - Projected Price to Earnings|TRVN: Price to Future Earnings Ratio|VIGL - Future Price to Earnings|Future Price to Earnings Multiple CERE (Cerevel Therapeutics)